Cargando…

The Potential Clinical Significance of the Biomarker IgA1

Detalles Bibliográficos
Autor principal:	Robert, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895585/ https://www.ncbi.nlm.nih.gov/pubmed/31845924 http://dx.doi.org/10.1016/j.ekir.2019.10.001

Ejemplares similares

Significance of serum galactose deficient IgA1 as a potential biomarker for IgA nephropathy: A case control study
por: Bagchi, Soumita, et al.
Publicado: (2019)

The Clinical Significance and Potential Role of Cathepsin S in IgA Nephropathy
por: Zhao, Jingying, et al.
Publicado: (2021)

Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy
por: Wada, Yukihiro, et al.
Publicado: (2018)

Clinical Significance of Serum Galactose-Deficient IgA1 Level in Children with IgA Nephropathy
por: Irabu, Hitoshi, et al.
Publicado: (2020)

Clinical Significance of the Intensity of Glomerular Galactose-Deficient IgA1 Deposition in IgA Nephropathy
por: Nakayama, Maiko, et al.
Publicado: (2022)

Renal vascular lesions in IgA nephropathy
por: Baradaran, Azar
Publicado: (2013)

Globally sclerotic glomeruli in IgA nephropathy patients
por: Mohammadi Torbati, Peyman
Publicado: (2012)

Toward a Clearer Picture of IgA Nephropathy in Spondyloarthritis
por: Canetta, Pietro
Publicado: (2020)

Origin and Homing of Intestinal IgA Antibody-secreting Cells
por: Lamm, Michael E., et al.
Publicado: (2002)

Latent IgA Deposition in Donated Kidneys in an Ethnically Diverse Population
por: Sofue, Tadashi
Publicado: (2020)

How Should Pathology Findings Influence Treatment in IgA Nephropathy?
por: Troyanov, Stéphan, et al.
Publicado: (2021)

T cells in IgA nephropathy: role in pathogenesis, clinical significance and potential therapeutic target
por: Ruszkowski, Jakub, et al.
Publicado: (2018)

C4d in IgA nephropathy: a marker sans boundaries
por: Mubarak, Muhammed
Publicado: (2016)

Diagnostic Significance of Reduced IgA in Children
por: Nurkic, Jasmina, et al.
Publicado: (2014)

Diagnostic Significance of Reduced IgA in Children
por: Nurkic, Jasmina, et al.
Publicado: (2015)

IgA1 protease
por: Mistry, Dippica, et al.
Publicado: (2006)

Clinical Relevance of Serum Galactose Deficient IgA1 in Patients with IgA Nephropathy
por: Kim, Jin Sug, et al.
Publicado: (2020)

Clinical significance of IgG deposition in the glomerular mesangial area in patients with IgA nephropathy
por: Wada, Yukihiro, et al.
Publicado: (2012)

Comment on: Association between the proportion of globally sclerotic glomeruli and various morphologic variables and clinical data of IgA nephropathy patients
por: Baradaran, Azar
Publicado: (2012)

Autoantibodies Specific for Galactose-Deficient IgA1 in IgA Vasculitis With Nephritis
por: Suzuki, Hitoshi, et al.
Publicado: (2019)

Biomarkers of IgA vasculitis nephritis in children
por: Pillebout, Evangeline, et al.
Publicado: (2017)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

Additional Refinement of CKD Prognostication Using Lymphatic Vessel Density: IgA Nephropathy as the Role Model?
por: Kronbichler, Andreas, et al.
Publicado: (2022)

IgA pemphigus showing IgA antibodies to desmoglein 1 and 3
por: Hegazy, Salama, et al.
Publicado: (2016)

Clinical Significance of Fecal Calprotectin for Evaluating Mucosal Inflammation with IgA Vasculitis
por: Kato, Riko, et al.
Publicado: (2022)

Clinical significance of urinary exosomal microRNAs in patients with IgA nephropathy
por: Yoon, Soo-Young, et al.
Publicado: (2023)

Osteopontin—A Potential Biomarker for IgA Nephropathy: Machine Learning Application
por: Moszczuk, Barbara, et al.
Publicado: (2022)

Low serum IgG4 level: a potential diagnostic biomarker for IgA nephropathy
por: Tian, Xinyu, et al.
Publicado: (2021)

Relationship between Gd-IgA1 and TNFR1 in IgA nephropathy and IgA vasculitis nephritis in children – multicenter study
por: Mizerska-Wasiak, Małgorzata, et al.
Publicado: (2021)

IgA Vasculitis and IgA Nephropathy: Same Disease?
por: Pillebout, Evangeline
Publicado: (2021)

Significance of subepithelial deposits in patients diagnosed with IgA nephropathy
por: Kitamura, Mineaki, et al.
Publicado: (2019)

Significance of segmental glomerulosclerosis in IgA nephropathy: What is the evidence?
por: Mubarak, Muhammed, et al.
Publicado: (2013)

Aberrantly Glycosylated IgA1 as a Factor in the Pathogenesis of IgA Nephropathy
por: Tanaka, Mototsugu, et al.
Publicado: (2011)

Aberrant IgA1 Glycosylation in IgA Nephropathy: A Systematic Review
por: Sun, Qiang, et al.
Publicado: (2016)

Pneumococcal IgA1 Protease Subverts Specific Protection By Human IgA1
por: Janoff, Edward N., et al.
Publicado: (2013)

The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy
por: Knoppova, Barbora, et al.
Publicado: (2016)

Bacterial IgA protease-mediated degradation of agIgA1 and agIgA1 immune complexes as a potential therapy for IgA Nephropathy
por: Wang, Li, et al.
Publicado: (2016)

Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
por: Suzuki, Hitoshi, et al.
Publicado: (2016)

IgA vasculitis update: Epidemiology, pathogenesis, and biomarkers
por: Xu, Liyun, et al.
Publicado: (2022)

The Role of Two Heart Biomarkers in IgA Nephropathy
por: Sági, Balázs, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0s99vslh518bfhj3e9dkrkruom